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Abstract
Background: Cigarette smoking is the main risk factor for the development of chronic obstructive pulmonary disease
(COPD), a major cause of morbidity and mortality worldwide. Despite this, the cellular and molecular mechanisms that
contribute to COPD pathogenesis are still poorly understood.
Methodology and Principal Findings: The objective of this study was to assess IL-1 a and b expression in COPD patients
and to investigate their respective roles in perpetuating cigarette smoke-induced inflammation. Functional studies were
pursued in smoke-exposed mice using gene-deficient animals, as well as blocking antibodies for IL-1a and b. Here, we
demonstrate an underappreciated role for IL-1a expression in COPD. While a strong correlation existed between IL-1a and b
levels in patients during stable disease and periods of exacerbation, neutrophilic inflammation was shown to be IL-1a-
dependent, and IL-1b- and caspase-1-independent in a murine model of cigarette smoke exposure. As IL-1a was
predominantly expressed by hematopoietic cells in COPD patients and in mice exposed to cigarette smoke, studies pursued
in bone marrow chimeric mice demonstrated that the crosstalk between IL-1a+ hematopoietic cells and the IL-1R1+
epithelial cells regulates smoke-induced inflammation. IL-1a/IL-1R1-dependent activation of the airway epithelium also led
to exacerbated inflammatory responses in H1N1 influenza virus infected smoke-exposed mice, a previously reported model
of COPD exacerbation.
Conclusions and Significance: This study provides compelling evidence that IL-1a is central to the initiation of smoke-
induced neutrophilic inflammation and suggests that IL-1a/IL-1R1 targeted therapies may be relevant for limiting
inflammation and exacerbations in COPD.
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Introduction
The adverse effect of cigarette smoking on human health is well
established [1,2]. Cigarette smoking is a main risk factor for lung
cancer and directly correlates with the development of chronic
obstructive pulmonary disease (COPD). According to WHO
estimates, 80 million people have moderate to severe COPD [3].
Episodes of acute exacerbation of COPD (AECOPD), often
requiring hospitalization, are typically caused by viral and/or
bacterial infections. While aberrant immune-inflammatory re-
sponses are likely key for driving increased inflammation observed
in COPD patients during stable disease and episodes of acute
exacerbations, the precise cellular and molecular mechanisms
remain to be elucidated.
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e28457IL-1 is a key family of cytokines implicated in both initiation and
persistence of inflammation [4]. Signaling through the IL-1
receptor type 1 (IL-1R1), IL-1a and IL-1b promote the production
of pro-inflammatory cytokines. For maximal activity to be
achieved, IL-1b requires processing by caspase-1 (within the
inflammasome complex), caspase-8, or MMP-9 [5,6,7], while IL-
1a is bioactive as either its pro- or processed form [4]. In man,
expression of IL-1b, in particular, has been shown to be increased
following cigarette smoke exposure [8] and in primary explant
cultures of bronchial epithelial cells derived from COPD patients
[9]. In animal models, we and others have shown that cigarette
smoke exposure significantly up-regulates IL-1b [10,11]. More
recently, Doz and colleagues demonstrated that cigarette smoke-
induced inflammation was dependent on IL-1R1 signaling [12],
while studies using caspase inhibitors have proposed an involve-
ment of the inflammasome and IL-1 cytokine maturation [11,12].
To-date, no studies in humans or mice have examined expression
and function of IL-1a in inflammatory processes associated with
cigarette smoke exposure and inflammatory exacerbation of stable
COPD, despite the multiple roles the IL-1 family members have
been shown to play in a multitude of inflammatory conditions
(reviewed in [13]).
Based on the aforementioned studies, we assessed expression of
IL-1a in COPD patients and investigated its functional relevance
to inflammatory processes elicited by cigarette smoke in mice.
Here, we show that IL-1a is expressed in stable COPD, and
increases in a correlative fashion with IL-1b during COPD
exacerbations. In mice, we demonstrate that smoke-induced
neutrophilic inflammation is dependent on IL-1a, but independent
of IL-1b. Furthermore, we provide evidence that IL-1R1
expression on structural cells is necessary and sufficient to elicit
smoke-induced neutrophilia. Finally, our data suggest that IL-1a/
IL-1R1-dependent activation of the airway epithelium is key for
driving the exacerbated inflammation following H1N1 influenza A
infection of smoke-exposed animals.
Results
IL-1a is increased in COPD patients and correlates with
increased IL-1b levels
Cigarette smoke elicits an inflammatory response in the lung
which is a distinctive feature of COPD [14]; moreover, inflamma-
tion is further increased during episodes of AECOPD [15,16]. The
molecularmechanismsdrivingthese inflammatoryresponsesremain
poorly understood. Since the IL-1 family of cytokines is important to
the initiation of an inflammatory response, we investigated the
expression of IL-1a and IL-1b in the lung of GOLD I/II COPD
patients (see Table S1 for patient demographics in the data
supplement). Lung section biopsies stained positively for both IL-
1a and b (Figure 1A and B, respectively, and see Figure S1 in data
supplement for control stains). Significantly increased numbers of
IL-1a and b positive cells were enumerated in biopsy samples taken
from GOLD I/II COPD patients compared to non-COPD controls
(Figure 1C). IL-1a expression was confined largely to the
inflammatory infiltrate, predominately on macrophages and the
occasional granulocyte. By contrast, IL-1b expression was more
widely distributed. Positive cells within the lamina propria were
predominately macrophages with a few granulocytes. While IL-1a
was not increased in the epithelium of COPD patients compared to
non-COPD controls, IL-1b staining was significantly increased
(p,0.0001) (Figure 1D and E, respectively). IL-1b positive cells
included structural cells within the epithelial segment, notably
metaplastic epithelial forms in both the airway epithelium and,
occasionally, glandular epithelium.
Although it has been established that IL-1b levels are
significantly increased in sputum recovered from COPD patients,
no study, to our knowledge has examined IL-1a levels. In an
exploratory study in COPD patients, levels of IL-1a and b
recovered from the sputum of COPD patients were significantly
correlated (p,0.0001) during stable disease, at the onset of
exacerbation (prior to additional treatment), and 7 and 35 days
post-exacerbation (Figure 1F–I). Correlation between IL-1a and b
was strongest at 7 days post exacerbation. In a subset of patients,
levels of IL-1a and b were increased at exacerbation compared to
levels measured during the stable disease visit. Taken together,
these data suggest a role for the IL-1 family members in stable
disease and during episodes of acute exacerbation.
IL-1a and IL-1b are increased in a model of cigarette
smoke exposure
To elucidate the functional importance of both IL-1a and IL-1b
in inflammatory processes associated with smoking, we examined
whether these cytokines were expressed in a mouse model of
cigarette smoke exposure. BALB/c mice were exposed to room air
or cigarette smoke twice daily for 4 days. Significantly increased
levels of IL-1a and IL-1b were observed in the lungs of cigarette
smoke-exposed mice compared to room air controls (Figure 2A
and B).
Immunohistochemical analysis revealed that expression of IL-
1a in control mice (room air) was confined to macrophages within
the alveolar spaces (Figure 2C). Occasionally, a low grade staining
was noted on intra-epithelial cells within the bronchiolar mucosa,
bronchiolar epithelial cells, and epithelial secretory cells. In smoke-
exposed mice, the key histological phenotype was a marked IL-1a
expression on the expanded alveolar macrophage population
(Figure 2C); although, IL-1a staining was also noted on some
hyperplastic bronchiolar epithelial cells (data not shown). Of note,
infiltrating cells within the bronchiolar and vascular adventitia
compartments were IL-1a negative.
In contrast to the IL-1a expression pattern, widespread tissue
expression of IL-1b was observed in room air and smoke-exposed
mice (Figure 2C). In room air controls, variable expression was
noted on the alveolar macrophage population. In addition, there
was unequivocal expression on alveolar type (AT) I and ATII cells,
especially the latter in the terminal alveolar buds, and on the
occasional hypertrophic ATII cell. In smoke-exposed animals, a
marked staining in the expanded alveolar macrophage population
was observed, as well as increased expression in both the ATI and
ATII cells, especially the hypertrophic forms. Widespread and
marked expression of IL-1b was also observed on the bronchiolar
epithelium, especially on hypertrophic cells, as well as epithelial
secretory cells. Collectively, these data indicate that tissue
expression of IL-1a and b in smoke-exposed mice involves a
similar population of both inflammatory infiltrate and resident
cells to that seen in COPD patients.
Cigarette smoke-induced inflammation is driven
independently of caspase-1
As the expression profile of IL-1a and b in cigarette smoke-
exposed mice mirrored the clinical observations shown in
Figure 1A and B, we used this experimental model as a platform
to examine the functional importance of IL-1a and IL-1b to
cigarette smoke-induced inflammation. We first exposed IL-1R1-
deficient and C57BL/6 wild-type mice to cigarette smoke for 4
days to assess the reported dependence of IL-1R1 signaling to
smoke-induced neutrophilic inflammation [11,12]. Neutrophilia
was completely attenuated in the bronchoalveolar lavage (BAL)
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type controls (Figure 2D and E, respectively). An IL-1R1
deficiency did not impact the increase in mononuclear cells in
the BAL of smoke-exposed mice (Figure 2F). The observed
increase in mononuclear cells was the result of increased numbers
of macrophages, as cigarette smoke exposure did not lead to an
increase in BAL lymphocytes (data not shown). While the
expression of neutrophil recruiting chemokines, CXCL -1, -2,
Figure 1. IL-1a and b are increased in the lung of chronic obstructive pulmonary disease patients. Representative images of IL-1a (A) and
b (B) expression in lung biopsies from GOLD I/II COPD patients. (C) Positive cells were enumerated from two biopsy samples obtained from each
patient (n=5 non-COPD and n=9 COPD GOLD stage I/II patients). Statistical significance was determined using a Generalized Linear Mixed Effect
model with negative binomial (adjusted for dispersion) to take into account multiple sampling of the same patient. Whiskers of box plots represent
1–99 percentile. Lung sections from the same biopsy samples were scored for IL-1a (D) and b (E) staining in the epithelium as follows: 0, no staining;
1, occasional staining; 2, marked focal staining; 3, marked diffuse staining. A stratified Wilcoxon Ranksum test was used to compare the frequencies of
the staining categories (0, 1, 2, and 3) and represented graphically (size of block is proportional to frequency). Levels of IL-1a and b were measured in
sputum samples obtained from patients at enrolment during stable disease (F), at onset of exacerbation (G), and days 7 (H) and 35 (I) post-
exacerbation.
doi:10.1371/journal.pone.0028457.g001
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PLoS ONE | www.plosone.org 3 December 2011 | Volume 6 | Issue 12 | e28457Figure 2. IL-1a and b expression in a smoke exposure model that induces IL-1R1-dependent and caspase-1-independent neutrophilia.
BALB/c mice were room air or cigarette smoke-exposed for 4 days. Total levels of IL-1a (A) and b (B) protein were measured by ELISA in lung homogenates
(n=5 mice per group). (C) Representative images showing expression of IL-1a and b in room air and smoke-exposed BALB/c mice. Insets represent
macrophagesfromtheinterstitialspace.Wild-typeandeitherIL-1R1-deficient(C57BL/6background)(n=5micepergroup)(D–F)orcaspase-1-deficient (G–
I) mice (NOD/ShiLt background) (n=3–6 mice per group) were room air or cigarette smoke-exposed for 4 days. Neutrophils (D and G) and mononuclear
cells (F and I) were assessed in the broncho-alveolar lavage (BAL) of room air and smoke-exposed mice. Percentage of Gr-1
hi cells were assessed by flow
cytometric analysis of room air and smoke-exposed whole lung tissue from wild-type and either IL-1R1-deficient (E) (n=5 mice per group) and caspase-1-
deficient (H) (n=4–6 mice per group) animals. Total levels of IL-1a (J) and b (K) protein were measured by ELISA from lung homogenates of room air and
smoke-exposed wild-type and caspase-1-deficient mice (n=4–6 mice per group). All data (B–K) are representative of two independent experiments.
doi:10.1371/journal.pone.0028457.g002
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an IL-1R1 deficiency significantly attenuated their induction
(Table S2 in online data supplement).
Given that caspase-1 cleaves pro-IL-1b into its bio-active form
and that this process has been shown to contribute to cigarette
smoke-induced neutrophilic inflammation [11,12], we exposed
caspase-1 deficient (NOD/ShiLt background) and the correspond-
ing wild-type control mice to cigarette smoke for 4 days.
Surprisingly, caspase-1 deficiency did not significantly alter
smoke-induced neutrophilia in the BAL or tissue (Figure 2H and
I, respectively). Similarly, the number of mononuclear cells in the
BAL was not attenuated in smoke-exposed caspase-1 deficient
mice compared to wild-type controls (Figure 2I). Of note, we
observed similar levels of total IL-1a and IL-1b protein in wild-
type and caspase-1 deficient mice (Figure 2J and K, respectively).
Cigarette-smoke induced neutrophilia is IL-1a dependent
IL-1R1 is the cognate receptor for both IL-1a and IL-1b [4].
Given the IL-1R1 dependency, we next investigated the relative
importance of IL-1a and IL-1b to smoke-induced neutrophilic
inflammation. We administered an anti-IL-1a or anti-IL-1b
blocking antibody, or an isotype control antibody daily to cigarette
smoke-exposed BALB/c mice. While anti-IL-1a intervention
abrogated smoke-induced neutrophilia (Figure 3A), neither anti-
IL-1b blockade nor administration of an isotype control impacted
cigarette smoke-induced inflammation. To corroborate these
findings, we exposed IL-1a-deficient and C57BL/6 wild-type
control mice to cigarette smoke for 4 days. Significantly decreased
numbers of neutrophils were observed in cigarette smoke-exposed
IL-1a-deficient mice compared to wild-type controls (Figures 3 B),
confirming our observations using blocking antibodies.
Figure 3. Cigarette smoke-induced neutrophilia is IL-1a dependent and IL-1b-independent. (A) 4 day cigarette smoke-exposed BALB/c mice
were either left untreated (No Rx), or administered an isotype antibody (IgG isotype), or either an anti-IL-1a or anti-IL-1b blocking antibody. Neutrophil
numbers were enumerated in the BAL (n=4–5 mice per group from one of two independent experiments). (B) Wild-type and IL-1a-deficient mice were
room air or cigarette smoke-exposed for 4 days. Data show BAL neutrophil numbers (n=6–8 mice per group). CXCL-1 (C) and IL-1b (D) expression (left
panels) were assessed in cigarette smoke-exposed and room air control BALB/c mice that were left untreated (No Rx), administered an isotype control
antibody (IgG isotype), or either an anti-IL-1a or anti-IL-1b blocking antibody. Expression of cxcl-1 and IL-1b transcripts was assessed by fluidigm array
andis presented relative to no treatment room air controlanimals (n=5 mice pergroup from oneof twoindependent experiments). Total protein levels
(right panels) of CXCL-1 (C) and IL-1b (D) were measured by MSD (n=10 mice per group from two independent experiments).
doi:10.1371/journal.pone.0028457.g003
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the lung of smoke-exposed mice, we assessed if neutrophil
recruiting chemokines were preferentially attenuated by anti-IL-
1a blockade. CXCL-1 had significantly increased RNA transcript
and protein expression following cigarette smoke-exposure
(Figure 3C). Anti-IL-1a, but not anti-IL-1b intervention signifi-
cantly attenuated expression of CXCL-1 RNA transcripts and
protein in smoke-exposed mice. Isotype antibody delivery did not
impact transcript or protein expression levels. Furthermore,
CXCL-2 and CXCL-5 gene expression, while increased following
smoke-exposure, were attenuated by anti-IL-1a, but not anti-IL-
1b blockade (Table S3 in the data supplement). Together, these
data suggest that the neutrophilic inflammation observed in
smoke-exposed animals requires the expression of CXCL -1, -2,
and -5, which are attenuated by blockade of IL-1a, but not IL-1b.
As both IL-1a and IL-1b signal through the IL-1R1, we next
studied whether IL-1a blockade attenuated expression of IL-1b.
Figure 3D shows significantly decreased IL-1b transcript and
protein levels in cigarette smoke-exposed mice that received anti-
IL-1a antibody. Similarly, we observed decreased expression of
GM-CSF, a cytokine that has recently been implicated in cigarette
smoke-induced inflammation [17,18] (refer to Table S3 in the data
supplement). Finally, as also shown in Table S3 in the data
supplement, we found that anti-IL-1a, but not anti-IL-1b blockade
significantly attenuated expression levels of the macrophage
elastase MMP-12. Collectively, these data suggest a critical role
for IL-1a, but not IL-1b in mediating cigarette smoke-induced
neutrophilia.
We next investigated whether neutrophilic inflammation
observed following chronic cigarette smoke exposure (8 weeks)
was also IL-1R1/IL-1a dependent. Decreased total cell numbers
were observed in both IL-1R1- and IL-1a-deficient mice following
chronic cigarette smoke exposure (Figures 4A and D, respectively).
Similar to the acute exposure protocol, smoke-induced neutro-
philia was significantly attenuated in both IL-1R1- and IL-1a-
deficient animals compared to C57BL/6 wild-type controls
(Figures 4C and F, respectively). Of note, we observed decreased
mononuclear cell numbers in IL-1R1 deficient mice (Figure 4C),
while no decrease was observed in IL-1a deficient animals.
Collectively, these data provide clear evidence that cigarette
smoke-induced neutrophilia is IL-1a dependent in both acute and
chronic cigarette smoke exposure models.
Expression of IL-1R1 on radio-resistant non-
hematopoietic cells is required for smoke-induced
inflammation
As the IL-1R1 was shown to play a fundamental role in
transducing the signals required for the initiation of acute and
chronic smoke-induced neutrophilia, we sought to examine the
expression profile of this receptor in the lung. Constitutive
expression of the IL-1R1 was primarily observed within the
alveolar epithelium of both ATI and ATII cell types (Figure 5A,
inset) in room air and cigarette smoke-exposed mice. A similar
expression pattern was mirrored in histological samples obtained
from COPD patients (Figure 5B and refer to Figure S2 in the data
supplement for control stains); although there was a clear
expression on alveolar wall mesenchymal elements, which
probably reflects enhanced remodeling in the clinical population
as well as greater heterogeneity of lesion. Collectively, these data
indicate that the alveolar epithelium is expressing IL-1R1 in both
humans and mice, while hematopoietic cells within the alveolar
space express IL-1a.
We thus hypothesized that crosstalk between hematopoietic and
non-hematopoietic cells is essential for cigarette smoke-induced
inflammation. To test this, we generated IL-1R1-deficient bone
marrow chimeric mice. Bone marrow cells from C57BL/6 wild-
type or IL-1R1-deficient mice were transferred intravenously to
irradiated wild-type or IL-1R1-deficient recipient mice (Figure 5C).
Following 8 weeks of reconstitution, mice were exposed to
cigarette smoke for 4 days and inflammatory parameters assessed.
Wild-type animals that received wild-type bone marrow cells (WT
Figure 4. Neutrophilia induced by chronic cigarette smoke exposure is IL-1R1/IL-1a dependent. Wild-type C57BL/6 and either IL-1R1- (A–
C) or IL-1a- (D–F) deficient mice were room air or cigarette smoke exposed for 8 weeks. Data show BAL total cell numbers (A and D), neutrophils (B
and E), and mononuclear cells (D and F) (A–C: n=4–5 mice per group from one of two independent experiments; D–F: n=5 nice per group).
doi:10.1371/journal.pone.0028457.g004
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smoke exposure (Figure 5D), whereas neutrophilia was absent in
IL-1R1-deficient animals reconstituted with IL-1R1-deficient bone
marrow cells (KO into KO). Chimeric mice, that resulted from the
transfer of wild-type hematopoietic cells into irradiated IL-1R1-
deficent mice (WT into KO), failed to elicit a neutrophilic response
to smoke, suggesting that IL-1R1 expression on non-hematopoi-
etic radio-resistant cells was essential for cigarette smoke-induced
inflammation. Finally, transfer of IL-1R1-deficient hematopoietic
cells into irradiated wild-type recipient mice (KO into WT)
showed a significant, but partial reduction in cigarette smoke-
induced neutrophilia.
We also investigated the expression of various genes, including,
CXCL-1, GM-CSF, and MMP-12 (Figure 5 E–G, respectively), all
of which were significantly attenuated in IL-1R1 deficient animals
reconstituted with IL-1R1 deficient bone marrow cells (KO into
KO). Interestingly, while cigarette smoke-exposed WT into KO
chimeric animals had significantly attenuated gene expression,
KO into WT animals did not significantly attenuate the genes
measured compared to WT into WT control animals. Therefore,
these data suggest that IL-1R1 mediated activation of non-
hematopoietic cells is a prerequisite for cigarette smoke-induced
inflammation, while IL-1R1 expression on hematopoietic cells is
required for maximal neutrophil infiltration.
IL-1R1 deficiency attenuates the differential response of
the smoke-exposed lung to viral stimulus
Having established that the IL-1a/IL-1R1 axis is central to
smoke-induced inflammation, and that both IL-1a and b levels
were increased in some patients during clinically unstable disease
(refer to Figure 1F–I), we next assessed whether similar
mechanisms may underlie the differential response of the smoke-
exposed lung to viral challenge [19,20,21,22]. We have previously
reported using precision cut lung slices (PCLS) that the smoke-
exposed lung is differentially primed to respond to viral insults
Figure 5. Expression pattern of IL-1R1 in smoke-exposed mice and COPD patients: requirement on radio-resistant non-
hematopoietic cells. (A) IL-1R1 expression in representative images from room air and smoke-exposed (4 days) C57BL/6 mice. (B) Representative
image of IL-1R1 expression as assessed in lung biopsies obtained from GOLD III COPD patients (see Figure S2 in the data supplement for isotype
stains). (C) Various chimeric mice (coded as bone marrow donor genotype into recipient genotype) were generated. (D) Neutrophils were
enumerated from the broncho-alveolar lavage (BAL) of bone marrow chimeric mice exposed to room air or cigarette smoke for 4 days (n=5–7 mice
per group). Expression of cxcl-1 (E), gm-csf (F), and mmp-12 (G) were measured by fluidigm array (n=6–8 mice per group). All data are representative
of one of two independent experiments.
doi:10.1371/journal.pone.0028457.g005
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initiating smoke-induced neutrophilic inflammation, as demon-
strated with the chimeric mouse experiments, we next sought to
assess the impact of smoke exposure on the response of lung resident
cells to viral stimulus. To this end, we exposed C57BL/6 wild-type
and IL-1R1-deficient animals to cigarette smoke for 4 days and
generated precision cut lung slices (PCLS). PCLS were stimulated
ex vivo with the dsRNA ligand, polyinosinic polycytidylic acid
(polyI:C), and expression of the key mediators were assessed. We
observed a significantly greater induction in response to polyI:C
stimulation of neutrophil recruiting chemokines, CXCL-1 and
CXCL-5, and a modest increase in CXCL-2 from PCLS
generated from smoke-exposed wild-type compared to room air-
exposed controls (Figure 6). All transcripts measured were
significantly attenuated in viral mimic-stimulated smoke-exposed
IL-1R1-deficient PCLS. Collectively, these data demonstrate a
role for lung resident cells in promoting smoke-induced inflamma-
tion and support a role for the IL-1R1 in the differential response
of the smoke-exposed lung to viral infection.
IL-1R1 deficiency and IL-1a antibody blockade attenuate
inflammation during influenza infection of cigarette
smoke-exposed mice
Having established the importance of IL-1a in mediating signals
via the IL-1R1 for the induction of smoke-induced inflammation,
and given the role that resident cells of the smoke-exposed lung were
shown to play in the response to viral mimic, we sought next to
assess if these mechanisms underlie the exacerbated inflammatory
response observed following viral infection in vivo [19,20,21,22].
C57BL/6 wild-type and IL-1R1-deficient mice were exposed to
cigarette smoke and subsequently infected with a H1N1 influenza
virus. In agreement with previous observations [22], an exacer-
bated inflammatory response was observed in the BAL of cigarette
smoke-exposed wild-type mice following viral infection compared
to virally-infected room air control mice (Figure 7A). While IL-
1R1 deficiency did not significantly affect total BAL inflammation
in smoke-exposed influenza-infected mice (p=0.089), neutrophilia
was significantly attenuated in these animals compared to wild-
type controls (Figure 7C). An IL-1R1-deficiency did not alter viral
burden in room air-exposed, infected control mice, while more
virus was recovered from the lungs of smoke-exposed IL-1R1-
deficient mice compared to wild-type controls (Figure 7D). Taken
together, these data suggest that an IL-1R1 dependent mechanism
contributes to exacerbation of the inflammatory response in
smoke-exposed mice following viral infection.
While an IL-1R1 deficiency could lessen exaggerated inflam-
matory responses in smoke-exposed influenza-infected animals, we
hypothesized that IL-1a would play a predominate role in
promoting this response. To test this, we injected animals daily
with the anti-IL-1a or isotype antibodies during the course of
cigarette smoke-exposure and viral infection. An exacerbated
response to influenza A virus, in cigarette smoke-exposed C57BL/
6 mice, was observed 5 days post-infection (Figure 7E). Anti-IL-1a
neutralization markedly attenuated BAL total inflammation, with
the effect significantly impacting mononuclear cells, but not
neutrophils (Figure 7F and G, respectively). Interestingly, anti-IL-
1a neutralization did not significantly impact viral burden in
smoke-exposed or room air control mice (Figure 7H). Taken
together these data provide evidence that therapies aimed at
blocking IL-1a/IL-1R1 may be beneficial during periods of
disease instability.
Discussion
According to World Health Organization estimates, 80 million
people have moderate to severe chronic obstructive pulmonary
disease [3]. Although emphasis has been placed on reducing
smoking prevalence, a greater understanding of the mechanisms
that contribute to COPD pathogenesis and exacerbation of the
stable disease are equally relevant given the burden this disease
places on health care systems, and the addictive nature and
chronic persistence of the cigarette smoking habit. Moreover, the
efficacy of many existing anti-inflammatory interventions have
been disappointing (reviewed in [23]), necessitating the design of
novel therapeutics. Given that IL-1 family members play a central
role in innate immune responses and in many pathogenic
inflammatory disorders, we assessed in humans and mice the role
of IL-1a and b, and their cognate receptor, IL-1R1, play in
promoting cigarette smoked-induced inflammation.
In this study, we report the presence of both IL-1a and b in
COPD patients. While previous studies have highlighted a role for
IL-1b in disease progression [8,9], we observed a strong
correlation between IL-1a and IL-1b levels in sputum obtained
from COPD patients in stable disease and during episodes of acute
exacerbation. Mechanistically, we demonstrate using blocking
antibodies and gene-deficient mice that cigarette smoke-induced
neutrophilia, as well as, expression of the neutrophil recruiting
chemokines CXCL -1, -2, and -5 was IL-1a dependent, but
independent of IL-1b. IL-1a antibody intervention also attenuated
expression of GM-CSF and MMP-12, two molecules that have
been implicated in cigarette smoke-induced inflammation and
Figure 6. IL-1R1 deficiency in smoke-exposed precision cut lung slices attenuates lung resident responses to viral stimulus. Wild-
type C57BL/6 and IL-1R1-deficient mice were exposed to room air or cigarette smoke for 4 days. PCLS were generated and stimulated ex vivo with a
viral mimic, polyI:C. Expression of cxcl-1 (A), cxcl-2 (B), and cxcl-5 (C) relative to room air control mock stimulated PCLS (data not shown) was assessed
by real time quantitative RT-PCR (n=7–14 lung slices from 3 independent experiments).
doi:10.1371/journal.pone.0028457.g006
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for IL-1a in the pathogenesis of COPD.
Recently, macrophages have been proposed to respond to
necrotic cells by releasing IL-1a [25]. Given that neutrophilia and
pathological tissue damage, including necrosis are key hallmarks of
COPD, it is plausible that IL-1a is released in COPD as a
consequence of such mechanisms. We have previously shown that
alveolar macrophages cultured ex vivo from smoke-exposed animals
produce significantly more IL-1a compared to controls [26]. Thus,
it would be of interest to examine the potential role of
macrophages for contributing to IL-1a driven responses, especially
given that macrophages have been suggested to be an orchestrat-
ing cell-type in COPD pathogenesis.
Our study suggests that caspase-1, the enzyme necessary for
processing IL-1b into its active form [27], was dispensable for
smoke-induced neutrophilic inflammation. Recently, two studies
in mice showed that smoke-induced inflammation was dependent
on signaling through the IL-1R1 [11,12]. While, Doz and
colleagues suggested that a caspase-1 inflammasome may be
important to the activation of IL-1b, Churg et al. demonstrated
using pharmacological caspase inhibitors that smoke-induced
inflammation and increased serum levels of IL-1b could be
attenuated. Although our observations are in contrast to those of
Churg et al., it remains to be addressed whether differences in
mouse strain, period of smoke exposure, or the specificity of the
pharmacological inhibitors are contributing factors. Interestingly,
Chen et al. demonstrated in vivo that caspase-1 was redundant in
the inflammatory response to dead cells [28], suggesting that this
response is dependent on IL-1a but independent of IL-1b, and
that necrotic events in cigarette smoke-exposed mice may be key
for driving smoke-induced neutrophilic inflammation.
Interestingly, IL-1a blockade markedly attenuated IL-1b
protein levels in the lung. Although not fully understood, this is
an important observation as over-expression of IL-1b has been
shown to contribute to emphysematous changes in mice [29].
Furthermore, a study by Castro et al. demonstrated that smoke-
induced mononuclear cell infiltrates were attenuated with an anti-
IL-1b antibody therapy [30]. Although IL-1b, in our model, does
not appear to be necessary for cigarette smoke-induced inflam-
mation, IL-1a up-regulation of IL-1b may provide a viable
hypothesis for the difference in interventions and may potentially
support the long term implications for the development of lung
tissue damage in chronic pulmonary disease.
Given that the IL-1R1 was predominantly expressed on the
airway epithelium and IL-1a was mainly restricted to hematopoi-
etic cells, we addressed whether crosstalk between the hemato-
poietic and non-hematopoietic compartments was required for
cigarette smoke-induced inflammation. Therefore, we generated
IL-1R1-deficient bone marrow chimeric mice and showed that IL-
1R1 signaling on non-hematopoietic structural cells, namely the
alveolar epithelium, was essential for cigarette smoke-induced
neutrophilic inflammation (Figure S3A in the data supplement),
while IL-1R1 signaling on hematopoietic cells (presumably
macrophages and dendritic cells) was required for maximal
cellular inflammation (Figure S3B in the data supplement). Taken
together, these data show that crosstalk, as depicted in Figure S3C
in the online data supplement, between IL-1a
+ hematopoietic cells
(such as macrophages) and IL-1R1
+ lung structural cells is key for
driving the inflammatory response to cigarette smoke. Although
IL-1a has been shown to drive inflammation via autocrine
stimulation of cells [31], expression of IL-1R1 on hematopoietic
cells (such as macrophages) is only partially involved in driving
smoke-induced inflammation, suggesting that activation of non-
hematopoietic cells by IL-1 is critical to the infiltration of
neutrophils to the lung.
We and others have previously shown that cigarette smoke
exposure exacerbates the inflammatory response elicited by
influenza A viruses in mice [19,20,21,22]. Given that lung
epithelial cells are the primary target of respiratory viruses, we
sought to assess whether IL-1R1 dependent activation of lung
resident cells was mediating the the exacerbated inflammatory
response. Indeed, IL-1R1 deficiency attenuated exacerbated
Figure 7. IL-1R1 deficiency and IL-1a antibody blockade attenuates inflammation in H1N1 influenza virus infected smoke-exposed
mice. (A–D) Wild-type C57BL/6 or IL-1R1-deficient mice were exposed to room air or cigarette smoke for 4 days. Mice were then instilled with vehicle
or infected with H1N1 influenza A virus. Five days post infection, total cell number (A), and mononuclear cell (B), and neutrophil (C) numbers were
enumerated from the broncho-alveolar lavage (BAL) (n=19–20 mice per group from four independent experiments) and viral burden was assessed
(D) (n=14–15 mice per group from three independent experiments). (E–H) Room air and smoke-exposed wild-type C57BL/6 mice treated daily with
either isotype or IL-1a blocking antibodies were instilled with vehicle or infected with a H1N1 influenza A virus. Five days post-infection, total cell
numbers (E), and mononuclear cell (F), and neutrophil (G) numbers were enumerated in the BAL and viral titers were assessed (H) (n=4–5 mice per
group).
doi:10.1371/journal.pone.0028457.g007
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infected animals. Using precision cut lung slices (PCLS) we
provide clear evidence that the resident cells within the smoke-
exposed lung produce greater levels of neutrophil recruiting
chemokines, CXCL -1, -2, and -5 in response to a dsRNA
stimulus. Of note, IL-1a blocking antibodies attenuated the
exacerbated inflammatory response in smoke-exposed influenza-
infected mice, suggesting that IL-1a blockade, while arguably
having the potential to interfere with the host response to viral
infection, in fact dampened the excessive inflammation observed
in these animals. In line with observations reported by Schmitz
and colleagues [32], we did not detect differences in viral burden
between room air wild-type and IL-1R1-deficient mice. Interest-
ingly, while no differences were observed in viral burden in anti-
IL-1a antibody treated smoke-exposed mice, an IL-1R1-deficiency
increased viral burden compared to wild-type controls. While it is
well understood that an IL-1R1-deficiency increases influenza-
related mortality at time-points later than were assessed in this
paper [32], studies are on-going to examine the outcome of IL-1a
blockade to antiviral responses (later than 5 days post-infection) in
smoke-exposed mice.
In COPD, chronic infiltration of the lung by neutrophils is
thought to play a key part in progression of the lung obstruction
due to collateral tissue damage induced by these cells. During an
exacerbation, release of further pro-inflammatory mediators and
an over-exuberant neutrophilic response might contribute to
progression of tissue damage and increase remodeling within the
lung. Therefore, attenuation of pro-inflammatory responses to
viruses may under these circumstances be beneficial. Collectively,
these data provide evidence that blockade of IL-1a has a potential
role in limiting disease exacerbation.
The results of our study demonstrate the importance of IL-1a
and its cognate receptor, IL-1R1, to the induction of cigarette
smoke-induced airway inflammation, and to the exacerbation of
inflammatory processes following viral infection of smoke-exposed
animals. Further, we identify that this response is independent of
caspase-1 and thus redundant of IL-1b signaling of its receptor.
Notably, crosstalk between IL-1a
+ hematopoietic cells and non-
bone-marrow derived IL-1R1
+ cells, was found to be essential for
governing smoke-induced inflammation. Collectively, these data
support a role for IL-1a/IL-1R1 therapy in the management of
smoke-induced inflammation and processes driving exacerbations
of COPD.
Materials and Methods
Ethics Statement
All clinical samples were collected according to the principals of
the Declaration of Helsinki, with patient informed written consent
and local institutional ethical approval from the North West
Research Ethics Committee, UK (application number 07/
MRE08/42) and the Royal Free Hospital Ethics Committee,
UK (reference number 06/Q0501/161). All human samples used
in this study were managed via AstraZeneca R&D Charnwood
Biobank facilities, and were analyzed anonymously by the authors.
All animal experimentations were conducted in compliance with
the Canadian Council on Animal Care and approved by The
Animal Research Ethics Board at McMaster University (animal
utilization protocol number 07-09-57).
Human biopsies and sputum samples
Lung sections were obtained from biopsies taken from GOLD I
and GOLD II COPD patients. Biopsy data from GOLD I (n=3,1
male and 2 females; all current smokers; mean 6 SD of FEV1/
FVC=6068%) and GOLD II (n=6, 4 males and 2 females; 2
current smokers; mean 6 SD of FEV1/FVC=56610%) COPD
patients were combined. Normal samples of central airway (for
comparison with COPD biopsy material) were all from non-
smokers with no significant respiratory or co-morbidities.
Alveolar bed expression profiles (for IL-1R1) were assessed in
lung sections obtained from GOLD III (n=5, 3 males and 2
females; 1 current smoker; mean 6 SD of FEV1/FVC=44610%)
COPD patients. Data were compared with non-COPD materials
obtained from cancer lobectomy from anatomically normal lobe
regions. Lobectomies were all from former smokers who had
ceased smoking for at least one year.
Sputum samples were obtained from COPD patients (demo-
graphics described in detail in Table S1 in the data supplement) at
enrolment during stable disease, at onset of exacerbation, and 7
days and 35 days post-exacerbation. Exacerbation was defined as
increase in two major symptoms (dyspnoea, sputum volume, or
sputum purulence) or one major and one minor symptom (cough,
wheeze, sore throat, nasal discharge, fever) over a 48 hr period.
Patients were given a normal standard of care under the
presenting circumstances, and sputum samples were taken at the
discretion of the study investigator.
Animals
BALB/c mice (6–8 weeks old) were purchased from Charles
River Laboratories (Montreal, Canada). 6–8 weeks old IL-1R1-
deficient mice (C57BL/6 background) and caspase-1-deficient
mice (NOD/ShiLt background), as well as their respective wild-
type controls were obtained from The Jackson Laboratories (Bar
Harbor, ME, USA). IL-1a- deficient mice [33] (obtained from YI)
were bred in-house. Mice were maintained under specific
pathogen-free conditions in an access-restricted area, on a 12-h
light-dark cycle, with food and water provided ad libitum.
Cigarette smoke exposure
Mice were exposed to cigarette smoke twice daily, five days per
week, using a whole body smoke exposure system (SIU-48,
Promech Lab AB, Vintrie, Sweden) as previously described
[10,26]. Briefly, mice were exposed to 12 2R4F reference
cigarettes with filters removed (Tobacco and Health Research
Institute, University of Kentucky, Lexington, KY, USA) for a
period of approximately 50 minutes, twice daily. Mice were
exposed to cigarette smoke for either 4 days or 8 weeks as detailed
in the results. This protocol of smoke exposure has been validated
and shown to achieve blood carboxyhaemoglobin and cotinine
levels that are comparable to those found in regular human
smokers [10]. Control animals were exposed to room air only.
Generation of IL-1R1-deficient bone marrow chimeric
mice
5 million C57BL/6 wild-type or IL-1R1-deficient bone marrow
cells were injected intravenously into irradiated (2 doses of
550Rads (11Gray total)) recipient C57BL/6 wild type (WT) or
IL-1R1-deficient (knockout (KO)) mice. Recipient mice were on
trimethoprim and sulfamethoxazole antibiotic-treated water one
week prior to irradiation and two weeks following irradiation.
Mice were allowed 8 weeks for reconstitution of hematopoietic
bone marrow cells.
Administration of antibodies and antibody inhibition
studies
Mice were injected intraperitoneally with 400 mg of anti-IL-1a
(clone ALF161; R&D Systems, Burlington, Canada), anti-IL-1b
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antibody (Jackson Immunoresearch, Burlington, Canada)
12 hours prior to the first smoke exposure, and then daily 1 hour
following the second smoke exposure. Influenza infected animals
also received daily intraperitoneal injections during the course of
infection.
Antibody inhibition studies (refer to Figure S4 in the data
supplement) were carried out in bEnd3 cells (mouse endothelial
IL-1 responsive cell line) that were cultured in DMEM, containing
10% FBS, 1% NEAA, sodium pyruvate, and 5 mM b-mercapto-
ethanol as per the supplier’s recommendations. Cells were plated
in 96 well plates and incubated at 37uC overnight. IL-1a or b
(74 pM final assay concentration) was pre-incubated with
titrations of antibodies at room temperature for 1 hr (26 final
assay concentration) and then 100 ml was added to the cells, and
incubated for 24 hrs at 37uC. Cell supernatants were diluted 1:5 in
PBS before being analyzed for murine KC using a standard KC
ELISA as per the manufacturer’s instructions (DY453, R&D
Systems).
Influenza infection and viral titer determination
Anesthetized mice were intranasally infected with 50 PFU of a
mouse-adapted H1N1 influenza A (A/FM/1/47-MA) virus as
previously described [22]. Control animals received 35 ml of PBS
vehicle. A/FM/1/47-MA is a fully sequenced, plaque-purified
preparation that is biologically characterized with respect to
mouse lung infections [34]. Animals were not exposed to cigarette
smoke on the day of viral delivery or for the entire course of the
viral infection.
Lung homogenates were used to determine viral titre on Madin-
Darby Canine Kidney (MDCK) monolayers. MDCK cells were
maintained in a-MEM supplemented with 10% fetal bovine
serum, 1% L-glutamine, and 1% penicillin/streptomycin. Con-
fluent monolayers of MDCK cells were washed twice with PBS to
remove serum. Serial dilutions of lung homogenate samples were
prepared and 200 ml of each was added to the MDCK monolayers
in 6 well dishes. Dishes were rocked and incubated at 37uC for
30 minutes. Agarose overlays (1:1 ratio of 1.3% agarose
(Biotechnology grade; Bioshop Canada INC., Burlington, Cana-
da), and 2xMEM/F-11 supplemented with 2% L-glutamine and
2% penicillin/streptomycin, containing 1 mg/ml trypsin-EDTA)
were applied and agarose allowed to solidify before replacing
dishes to 37uC. Plaque assays were fixed using Carnoy’s Fixative
(75% methanol and 25% glacial acetic acid) two days later.
Plaques were enumerated and viral titres were expressed as the
number of infectious plaque forming units per gram of lung tissue.
Collection and measurement of specimens
Bronchoalveolar lavage (BAL) fluid was collected, total cells
enumerated, and differential cell counts obtained as previously
described [10,22,26,35].
Flow cytometric analysis
Two lobes from the multilobe side of the lung was cut into
,2 mm pieces, shaken for 1 h at 37uC in 150 U/ml collagenase
type I (Gibco, Burlington, Canada) in HBSS, pressed through
nylon mesh, washed twice in HBSS, and counted on a
hemacytometer. Cells were washed, and re-suspended in 25 ml
of staining cocktail for 30 min at 4uC. Antibodies used in this study
include anti-CD45 (Allophycocyanin (APC)-cy7-conjugated, 30-
F11, BD Biosciences, San Jose, CA, USA), anti-MHC class II (I-
A/I-E) (APC-conjugated, M5/144.15.2, eBiosciences, San Diego,
CA, USA), and anti-Gr-1 (Pacific Orange-conjugated, RB6-8C5,
Invitrogen, Burlington, Canada), as well as appropriate isotype
control antibodies (BD, San Jose, CA, USA and eBiosciences, San
Diego, CA, USA). Fluorescence minus one staining cocktails and
isotype control antibodies (BD Biosciences and eBiosciences) were
used to distinguish background staining from positive signals. Flow
cytometric data was acquired using an LSRII flow cytometer (BD
Biosciences, San Jose, CA, USA). Data were analyzed with FlowJo
Software (Tree Star, Ashland, OR, USA).
Histological analysis and immunohistochemistry
For human expression of IL-1a and b, and IL-1R1 antigen
retrieval was performed by incubating sections in 0.2% trypsin/
0.2% CaCl2 in distilled H2Oa t3 7 uC for 10 minutes. Endogenous
peroxidase activity was blocked using 6% H202 for 10 mins. To
block non-specific binding of the secondary antibody, slides were
incubated with 20% normal rabbit or goat serum for 20 minutes.
Excess serum was removed and slides were incubated with either
IL-1a rabbit anti-human antibody (Abcam, 9614, 2.5 mg/ml), IL-
1b rabbit anti-human antibody (Abcam, 2105, 10 mg/ml) or IL-
1RI goat anti-human antibody (R&D Systems, Ab-269-NA,
10 mg/ml) or either rabbit or goat IgG negative control for
1 hour. Slides were incubated with biotinylated rabbit anti-goat
secondary (1:200) or swine anti-rabbit secondary (1:200) antibody
for 20 minutes. Two antigen detection protocols were employed
on the human tissue sets: 1) Strep ABComplex/HRP (Dako) for
20 minutes at room temperature, 2610 minutes buffer wash and
DAB applied for 1 minute. 2) Strep ABComplex/AP (Dako) for
30 minutes at room temperature, 2610 minutes buffer wash and
Fuchsin Substrate-Chromagen System (Dako) for 5 minutes.
Slides were counterstained with haematoxylin (Sigma). Positive
cells were counted from two separate biopsy samples from each
patient taken approximately 10 mm apart. A 250 mm
2 graticule
was aligned to the basement membrane and cells counted in the
lamina propria in 3 adjacent regions. Identification of positive cells
was based on cytological morphology, comparing the relevant
antibody stained sections with parallel haematoxylin and eosin
stained sections. Many of the macrophages showed distinctive
phagolysosome inclusions and granulated cytoplasm, whereas the
granulocytes showed a distinctive granulated cytoplasm and
typical nuclear morphology. Lung sections from the same biopsy
samples were scored for IL-1a and b staining in the epithelium as
follows: 0, no staining; 1, occasional staining; 2, marked focal
staining; 3, marked diffuse staining.
For mouse expression of IL-1R1, 5 mg/ml of goat anti-mouse
IL-1R1 antibody (R&D Systems, Minneapolis, MN, USA) was
incubated on the slides for 1 hour. For the IL-1a and IL-1b stain,
prior to the primary antibody incubation Rodent M Block
(Biocare Medical, Concord, CA, USA) was added to each slide
for 30 minutes, and then washed away with a Tris-buffered saline
with 0.05% Tween-20 (TBS-T). 10 mg/ml of goat anti-mouse IL-
1a and IL-1b (R&D Systems, Minneapolis, MN, USA) were
prepared in Ultra Antibody Diluent (Thermo Scientific, Rockford,
IL, USA) and incubated with the slides for 1 hour. A secondary
goat polymer horse-radish peroxidase was used according to the
manufacturer’s instructions (BioCare Medical; Concord, CA,
USA).
RNA extraction for fluidigm analysis
RNA was extracted from mouse lung using the Qiagen RNeasy
Fibrous Tissue kit (Qiagen, Hilden, Germany). RNA was
quantified and normalized, and RNA integrity was assessed by
Agilent Bioanalyzer using the Agilent RNA 6000 Nano Kit
(Agilent, Santa Clara, CA, USA). cDNA generation was carried
out with the Super Script III kit from Life Technologies utilizing
the manufacturer’s protocol (Life Technologies, Carlsbard, CA,
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Fluidigm Biomark Dynamic array loaded with probes for
transcripts of interest as previously described [36].
ELISA and meso scale discovery (MSD) analysis
ELISA kits for IL-1a and IL-1b were purchased from R&D
Systems (Minneapolis, MN, USA). Multi-array platform cytokine
detection of KC and IL-1b was done using the multi-array murine
pro-inflammatory and Th1/Th2 cytokine panel detection systems
developed by Meso Scale Discovery (MSD; Gaithersburg, MD,
USA).
Precision cut lung slicing and culture
Lungs were sliced using a modification to a standard protocol
that has previously been described [22]. Briefly, lungs were
inflated with approximately 1.4 ml of agarose (type VII-A low
gelling temperature; Sigma Aldrich, St. Louis, MO, USA) that was
warmed to 37uC and prepared to a concentration of 2% in Hank’s
buffered saline solution (HBSS), supplemented with N-2-hydro-
xyethlypiperazine-N9-2-ethanesulphonic acid (HEPES) (0.2 M,
pH 7.4). Subsequently, 0.2 ml of air was injected into the lung
in order to flush the agarose-HBSS solution out of the conducting
airways. The agarose was allowed to gel by cooling the lung to 4uC
for 15 minutes. The lung lobes were dissected away and a flat
surface was cut on the lobe parallel and caudal to the main
bronchus. The lung lobes were maintained in an ice-cold 16
HBSS solution prior to and during slicing. 120 mm thick slices
were generated using a vibratome (Leica; model VT 1000S,
Richmond Hill, Canada) at 4uC. Approximately 40 slices were
isolated from each mouse lung.
Lung slices were subsequently transferred to and cultured in
Dulbecco’s Modified Eagles Medium (DMEM)/F12 (Gibco,
Burlington, Canada) supplemented with 35 mg/ml L-Ascorbic
Acid (Sigma-Aldrich, Oakville, Canada), 5 mg/ml Transferin
(Gibco, Burlington, Canada), 2.85 mg/ml Insulin (Sigma-Aldrich,
Oakville, Canada), and 3.25 ng/ml Selenium (atomic absorption
standard solution; Sigma-Aldrich, Oakville, Canada). The solution
was filter-sterilized using a 0.22 mm pore filter. The DMEM/F12
solution was further supplemented with 250 ng/ml Amphotericin
B (Sigma-Aldrich, Oakville, Canada) and 1% penicillin/strepto-
mycin. The medium was changed every 1 h for the first 3 h of
culture in order to remove any remaining agarose and cell debris
from the lung slice culture. Lung slices were stimulated the next
day for 6 hours with 100 ug/ml of dsRNA mimetic polyinosinic-
polycytidylic acid (GE Healthcare, Mississauga, Canada) that was
reconstituted in phosphate buffered saline or were left untreated.
Samples were collected in RNA later (Ambion, Austin, TX, USA)
and preserved at 280uC until extraction of RNA.
RNA extraction and real-time quantitative RT PCR for
precision cut lung slices
Lung slices were collected as previously described [22]. RNA
was extracted from the lung slices according to the RNEasy Kit
(Qiagen, Mississauga, ON, Canada). Optional on-column DNase
digestion was performed during RNA extraction using the
RNEasy Kit (Qiagen, Mississauga, ON, Canada). RNA was
quantified using the Agilent 2100 Bio-analyzer (Agilent Technol-
ogies, Mississauga, ON, Canada). The quantity and integrity of
isolated RNA was determined using the Agilent 2100 Bioanalyzer
(Agilent, Palo Alto, CA, USA). Subsequently, 100 ng of total RNA
was reverse-transcribed using 100 U of Superscript II (Invitrogen,
Burlington, Canada) in a total volume of 20 mL. Random hexamer
primers were used to synthesize cDNA at 42uC for 50 min,
followed by 15 min incubations at 70uC. Real-time quantitative
RT-PCR was performed in triplicate, in a total volume of 25 ml,
using a Universal PCR Master Mix (Applied Biosystems, Foster
City, CA, USA). Primers for CXCL-1, CXCL-1, CXCL-2,
CXCL-5, GAPDH, along with FAM-labeled probes were
purchased from Applied Biosystems. PCR was performed using
the ABI PRISM 7900HT Sequence Detection System using the
Sequence Detector Software version 2.2 (Applied Biosystems,
Foster City, CA, USA). Data were analyzed using the delta, delta
Ct method. Briefly, gene expression was normalized to the
housekeeping gene (GAPDH) and expressed as fold change over
the control group (room air control, mock).
Data and statistical analysis
Data were presented and expressed as mean 6 SEM using
Graphpad Prism Software version 5 (La Jolla, CA, USA).
Statistical analysis was performed with SPSS statistical software,
version 17.0 (Chicago, IL, USA). For all human samples, statistical
analysis were performed using R, version 2.11.1 (Vienna, Austria).
In mouse experiments, we assessed significance (p,0.05) using the
SPSS Univariate General Linear Model, t-tests were subsequently
performed for two-group comparisons or one-way ANOVA with a
Dunnett post-hoc test for multiple group comparisons, unless
otherwise stated.
Supporting Information
Figure S1 IL-1a and b are increased in the lung of COPD
patients. Representative images showing expression of IL-1a (A)
and b (B) isotype control stains as assessed in lung biopsy sections
obtained from GOLD III COPD patients.
(TIF)
Figure S2 IL-1R1 expression in the lung of a COPD
patient. Representative image of IL-1R1 isotype control stained
lung biopsy section obtained from a GOLD III COPD patient.
(TIF)
Figure S3 Model of IL-1a crosstalk between the hema-
topoietic and non-hematopoietic compartments. (A)
Absence of the IL-1R1 on non-hematopoietic cells, as depicted
on the airway epithelium completely attenuates smoke-induced
inflammation. (B) Absence of the IL-1R1 on hematopoietic
(macrophages and dendritic cells) leads to attenuated neutrophilic
inflammation that is not entirely abrogated. (C) IL-1R1 is required
on cells in both the hematopoietic and non- hematopoietic
compartments for cross-talk to occur and maximal smoke-induced
neutrophilic inflammation to result.
(TIF)
Figure S4 Antibody inhibition of IL-1 induced KC
release from bEnd3 cells. Murine IL-1a and b induced KC
release was measured from bEnd3 cells, a murine endothelial cell
line. (A) Murine IL-1b (74 pM) induced KC release was inhibited
by MAB4012, and not by MAB4001 (B) Murine IL-1a (74 pM)
induced KC release was inhibited by MAB4001, but not by
MAB4012. Data shown is a single experiment representative of
n=3.
(TIF)
Table S1 Study population characteristics, (n=14), for
sputum cohort.
(DOC)
Table S2 Expression profile of various mediators in IL-
1R1-deficient animals.
(DOC)
Mechanisms of Cigarette Smoke-Induced Inflammation
PLoS ONE | www.plosone.org 12 December 2011 | Volume 6 | Issue 12 | e28457Table S3 Expression profile of various mediators
following anti-IL-1 –a and –b intervention.
(DOC)
Acknowledgments
The authors gratefully acknowledge the expert technical support of Sussan
Kianpour, Joanna Kasinska, Mary Bruni, and Mary Jo Smith, Alba Llop-
Guevara, and the secretarial assistance of Marie Colbert at McMaster
University. Ashley E. Keller at MedImmune LLC for Fluidigm assessment.
Richard Arthur and Paul Dodson (Research and Development, AstraZe-
neca, Charnwood, UK) are also acknowledged for input on the acquisition
of human sputum data. The expert statistical interpretation of the human
data by Athula Herath was also appreciated. The authors also express
thanks to Joel Zylstra for artistic rendering of the mouse and cells presented
in Figure 5.
Author Contributions
Conceived and designed the experiments: FMB CMTB DF AAH MRS.
Performed the experiments: FMB CMTB JKN CCJZ AK KNL SP.
Analyzed the data: FMB CMTB DF AAH MRS. Contributed reagents/
materials/analysis tools: MLF JJPG JAW J. Bassett J. Bramson YI. Wrote
the paper: FMB CMTB MRS. Discussion and feedback: MS RK AJC.
References
1. Patel RR, Ryu JH, Vassallo R (2008) Cigarette smoking and diffuse lung disease.
Drugs. pp 1511–1527.
2. Kim V, Rogers TJ, Criner GJ (2008) New concepts in the pathobiology of
chronic obstructive pulmonary disease. Proceedings of the American Thoracic
Society. pp 478–485.
3. Holmes J (2010) 10 Facts on the Tobacco Epidemic and Global Tobacco
Control World Health Organization.
4. Dinarello CA (2009) Immunological and inflammatory functions of the
interleukin-1 family. Annu Rev Immunol. pp 519–550.
5. Schroder K, Tschopp J (2010) The inflammasomes. Cell. pp 821–832.
6. Maelfait J, Vercammen E, Janssens S, Schotte P, Haegman M, et al. (2008)
Stimulation of Toll-like receptor 3 and 4 induces interleukin-1beta maturation
by caspase-8. J Exp Med. pp 1967–1973.
7. Scho ¨nbeck U, Mach F, Libby P (1998) Generation of biologically active IL-1
beta by matrix metalloproteinases: a novel caspase-1-independent pathway of
IL-1 beta processing. J Immunol. pp 3340–3346.
8. Kuschner WG, D’Alessandro A, Wong H, Blanc PD (1996) Dose-dependent
cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J
9: 1989–1994.
9. Rusznak C, Mills PR, Devalia JL, Sapsford RJ, Davies RJ, et al. (2000) Effect of
cigarette smoke on the permeability and IL-1beta and sICAM-1 release from
cultured human bronchial epithelial cells of never-smokers, smokers, and
patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol
23: 530–536.
10. Botelho FM, Gaschler GJ, Kianpour S, Zavitz CC, Trimble NJ, et al. (2009)
Innate Immune Processes are Sufficient for Driving Cigarette Smoke Induced
Inflammation in Mice. Am J Respir Cell Mol Biol.
11. Churg A, Zhou S, Wang X, Wang R, Wright JL (2009) The role of interleukin-
1beta in murine cigarette smoke-induced emphysema and small airway
remodeling. Am J Respir Cell Mol Biol 40: 482–490.
12. Doz E, Noulin N, Boichot E, Guenon I, Fick L, et al. (2008) Cigarette smoke-
induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88
signaling dependent. J Immunol 180: 1169–1178.
13. Sims JE, Smith DE. The IL-1 family: regulators of immunity. Nat Rev Immunol
10: 89–102.
14. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS (2001) Global
strategy for the diagnosis, management, and prevention of chronic obstructive
pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive
Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163:
1256–1276.
15. Aaron SD, Angel JB, Lunau M, Wright K, Fex C, et al. (2001) Granulocyte
Inflammatory Markers and Airway Infection during Acute Exacerbation of
Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 163:
349–355.
16. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, et al. (2006)
Infections and airway inflammation in chronic obstructive pulmonary disease
severe exacerbations. Am J Respir Crit Care Med 173: 1114–1121.
17. Vlahos R, Bozinovski S, Chan SP, Ivanov S, Linden A, et al. Neutralizing
granulocyte/macrophage colony-stimulating factor inhibits cigarette smoke-
induced lung inflammation. Am J Respir Crit Care Med 182: 34–40.
18. Botelho FM, Nikota JK, Bauer C, Davis NH, Cohen ES, et al. A mouse GM-
CSF receptor antibody attenuates neutrophilia in mice exposed to cigarette
smoke. Eur Respir J 38: 285–294.
19. Robbins CS, Bauer CM, Vujicic N, Gaschler GJ, Lichty BD, et al. (2006)
Cigarette Smoke Impacts Immune Inflammatory Responses to Influenza in
Mice. Am J Respir Crit Care Med.
20. Gualano RC, Hansen MJ, Vlahos R, Jones JE, Park-Jones RA, et al. (2008)
Cigarette smoke worsens lung inflammation and impairs resolution of influenza
infection in mice. Respir Res 9: 53.
21. Kang MJ, Lee CG, Lee JY, Dela Cruz CS, Chen ZJ, et al. (2008) Cigarette
smoke selectively enhances viral PAMP- and virus-induced pulmonary innate
immune and remodeling responses in mice. J Clin Invest 118: 2771–2784.
22. Bauer CMT, Zavitz CCJ, Botelho FM, Lambert KN, Brown EG, et al. (2010)
Treating Viral Exacerbations of Chronic Obstructive Pulmonary Disease:
Insights from a Mouse Model of Cigarette Smoke and H1N1 Influenza
Infection. PLoS ONE 5: e13251.
23. Falk JA, Minai OA, Mosenifar Z (2008) Inhaled and Systemic Corticosteroids in
Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 5: 506–512.
24. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD (1997) Requirement
for macrophage elastase for cigarette smoke-induced emphysema in mice.
Science 277: 2002–2004.
25. Rock KL, Latz E, Ontiveros F, Kono H. The sterile inflammatory response.
Annu Rev Immunol 28: 321–342.
26. Gaschler GJ, Skrtic M, Zavitz CC, Lindahl M, Onnervik PO, et al. (2009)
Bacteria challenge in smoke-exposed mice exacerbates inflammation and skews
the inflammatory profile. Am J Respir Crit Care Med 179: 666–675.
27. Li P, Allen H, Banerjee S, Franklin S, Herzog L, et al. (1995) Mice deficient in
IL-1 beta-converting enzyme are defective in production of mature IL-1 beta
and resistant to endotoxic shock. Cell. pp 401–411.
28. Chen CJ, Kono H, Golenbock D, Reed G, Akira S, et al. (2007) Identification of
a key pathway required for the sterile inflammatory response triggered by dying
cells. Nat Med 13: 851–856.
29. Lappalainen U, Whitsett JA, Wert SE, Tichelaar JW, Bry K (2005) Interleukin-
1beta causes pulmonary inflammation, emphysema, and airway remodeling in
the adult murine lung. Am J Respir Cell Mol Biol 32: 311–318.
30. Castro P, Legora-Machado A, Cardilo-Reis L, Valenca S, Porto LC, et al. (2004)
Inhibition of interleukin-1beta reduces mouse lung inflammation induced by
exposure to cigarette smoke. Eur J Pharmacol 498: 279–286.
31. Schultz K, Murthy V, Tatro JB, Beasley D (2007) Endogenous interleukin-1
alpha promotes a proliferative and proinflammatory phenotype in human
vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. pp H2927–2934.
32. Schmitz N, Kurrer M, Bachmann MF, Kopf M (2005) Interleukin-1 is
responsible for acute lung immunopathology but increases survival of respiratory
influenza virus infection. J Virol 79: 6441–6448.
33. Horai R, Asano M, Sudo K, Kanuka H, Suzuki M, et al. (1998) Production of
mice deficient in genes for interleukin (IL)-1alpha, IL-1beta, IL-1alpha/beta,
and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-
induced fever development and glucocorticoid secretion. J Exp Med 187:
1463–1475.
34. Brown EG (1990) Increased virulence of a mouse-adapted variant of influenza
A/FM/1/47 virus is controlled by mutations in genome segments 4, 5, 7, and 8.
J Virol 64: 4523–4533.
35. Gaschler GJ, Zavitz CC, Bauer CM, Skrtic M, Lindahl M, et al. (2008) Cigarette
smoke exposure attenuates cytokine production by mouse alveolar macrophages.
Am J Respir Cell Mol Biol 38: 218–226.
36. Yao Y, Higgs BW, Morehouse C, De Los Reyes M, Trigona W, et al. (2009)
Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-
IFN-a Monoclonal Antibody Trials in Systemic Lupus Erythematosus. Human
Genomics and Proteomics. pp 1–17.
Mechanisms of Cigarette Smoke-Induced Inflammation
PLoS ONE | www.plosone.org 13 December 2011 | Volume 6 | Issue 12 | e28457